Drugmaker Mallinckrodt emerges from bankruptcy
(Reuters) -Drugmaker Mallinckrodt said on Tuesday it has emerged from bankruptcy and reduced its total funded debt by about $1.9 billion. Mallinckrodt, which won court approval for its bankruptcy plan…
(Reuters) -Drugmaker Mallinckrodt said on Tuesday it has emerged from bankruptcy and reduced its total funded debt by about $1.9 billion. Mallinckrodt, which won court approval for its bankruptcy plan…
(Reuters) – Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the matter. Deliberations are ongoing and…
(Reuters) – Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids, the Wall Street Journal reported on Wednesday.…
By Joe Cash and Brenda Goh BEIJING (Reuters) – Global drugmaker AstraZeneca will seek to be a patriotic company in China that “loves the Communist Party”, its China president said…
ZURICH (Reuters) – Roche has bought 540,000 of its own shares, the company said on Friday, as a member of its controlling family group scaled back their investment in voting…
PARIS (Reuters) -French drugmaker Sanofi said it expected a positive boost to its third-quarter business results from movements on the currency markets, helped by the strength of the U.S. dollar…
By Michael Erman NEW YORK – The U.S. Senate Finance Committee is widening its investigation into the tax practices of U.S. drugmakers to include Amgen Inc, according to a letter…
By Nancy Lapid (Reuters) – Drugmaker Gilead Sciences plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and…
(Reuters) -Amarin Corp Plc said on Monday it would cut its workforce by 40%, as the drugmaker’s fish-oil derived heart drug faces stiff competition from generic rivals in the United…
By Steven Scheer JERUSALEM -Teva Pharmaceutical Industries said on Wednesday it was bracing to pay as much as $3.6 billion in cash and medicine to settle thousands of lawsuits alleging…
– Belgian drugmaker Galapagos NV on Wednesday named former Johnson & Johnson senior executive Paul Stoffels as its chief executive officer, effective April 1. Stoffels was the chief scientific officer…
(This Dec. 30 story refiles to add dropped words “members of” in last paragraph) By Brendan Pierson NEW YORK – Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York…